
    
      The extension protocol is a continuation of treatment with IPI-926, as administered to each
      individual patient during participation in their original IPI-926 protocol.

      Patients who are completing their participation in the original IPI-926 protocol in which
      they enrolled, as defined in the original protocol, and, have stable disease or confirmed
      complete or partial response as defined by the original protocol may continue to receive
      treatment with IPI-926 in the extension protocol.
    
  